CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting
SHANGHAI, June 2, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of the pivotal Phase II clinical trial in China...
JA Solar's Bycium+ Cell Achieves Record-Breaking 748.6mV Open-Circuit Voltage Certified by ISFH
BEIJING, Dec. 16, 2024 /PRNewswire/ -- JA Solar's Bycium+ cell has achieved a significant breakthrough, having reached a new high in cell efficiency and set a new record with an open-circuit voltage of 748.6mV—the highest in the commercial TOPCon PV...